IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

BACKGROUND: Reactivation of the varicella zoster virus (VZV) is more common in patients with malignancies; however, the molecular and cellular mechanisms underlying this susceptibility are unclear. METHODS: Using ex vivo interferon-gamma ELISpot assays, we set out to analyse VZV-specific immune resp...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Malavige, G, Rohanachandra, LT, Jones, L, Crack, L, Perera, M, Fernando, N, Guruge, D, Ogg, G
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.
de réir: Jones, L, et al.
Foilsithe / Cruthaithe: (2007)

Phenotypic analysis of human CD4+ T cells specific for immediate early 63 protein of varicella-zoster virus
de réir: Jones, L, et al.
Foilsithe / Cruthaithe: (2008)

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus
de réir: Crack, L, et al.
Foilsithe / Cruthaithe: (2012)

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus.
de réir: Crack, L, et al.
Foilsithe / Cruthaithe: (2012)

Immune evasion during varicella zoster virus infection of keratinocytes.
de réir: Black, A, et al.
Foilsithe / Cruthaithe: (2009)

Viral loads in primary varicella zoster virus infection
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2008)

Phenotypic analysis of human CD4+T cells specific for IE63 protein of VZV
de réir: Jones, L, et al.
Foilsithe / Cruthaithe: (2008)

Natural Killer Cells During Primary Varicella Zoster Virus Infection.
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2010)

Varicella-zoster virus vaccine is able to evade the T-cell response during the replicative phase of the viral life cycle
de réir: Black, A, et al.
Foilsithe / Cruthaithe: (2008)

Investigation of Varicella Zoster virus-specific T cell responses
de réir: Jones, L, et al.
Foilsithe / Cruthaithe: (2005)

Varicella zoster virus inhibition of toll-like receptor 3 signalling in keratinocytes - a novel immune evasion strategy
de réir: Black, A, et al.
Foilsithe / Cruthaithe: (2008)

Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection.
de réir: Jones, L, et al.
Foilsithe / Cruthaithe: (2006)

Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2007)

Investigation of varicella zoster virus glycoprotein-specific T cell responses
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2007)

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2008)

Varicella zoster virus (VZV)-specific immunity and subclinical VZV reactivation in patients with autoimmune diseases
de réir: Kwang-Hoon Lee, et al.
Foilsithe / Cruthaithe: (2021-07-01)

A model of varicella-zoster reactivation
de réir: Jonathan E. Forde, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.
de réir: Malavige, G, et al.
Foilsithe / Cruthaithe: (2008)

The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation
de réir: Peter G. E. Kennedy
Foilsithe / Cruthaithe: (2023-07-01)

Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka
de réir: Hathshya M Munasingha, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Pneumonia a Varicella zoster Varicella zoster pneumonia
de réir: Carla Ferreira Santos, et al.
Foilsithe / Cruthaithe: (2010-06-01)

Silent Reactivation of Varicella Zoster Virus in Pregnancy: Implications for Maintenance of Immunity to Varicella
de réir: Mirella Mourad, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Varicella-Zoster Virus in Perth, Western Australia: Seasonality and Reactivation.
de réir: Igor A Korostil, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.
de réir: Gathsaurie Neelika Malavige, et al.
Foilsithe / Cruthaithe: (2008-01-01)

Trigeminal neuralgia due to Varicella-zoster virus reactivation
de réir: Denise Jourdan Oliveira, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Covid-19 Vaccination and Reactivation of Varicella Zoster Virus
de réir: Maryam Sadat Sadati
Foilsithe / Cruthaithe: (2022-11-01)

Myelitis and Radiculitis Complicating Varicella-Zoster Virus Reactivation
de réir: Diogo Goulart Corrêa, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation
de réir: Nicholas L. Baird, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency
de réir: Werner J. D. Ouwendijk, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Atypical varicella-zoster virus reactivation: a case report
de réir: Francesca Salvotti, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons
de réir: Heather S. Pomerantz, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
de réir: Daniel Gelman, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)
de réir: Chang, C, et al.
Foilsithe / Cruthaithe: (2009)

Mutagenesis of the Varicella-Zoster Virus Genome Demonstrates That VLT and VLT-ORF63 Proteins Are Dispensable for Lytic Infection
de réir: Shirley E. Braspenning, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Focal Encephalitis Following Varicella-Zoster Virus Reactivation without Rash
de réir: J Gordon Millichap, et al.
Foilsithe / Cruthaithe: (2014-10-01)

Cerebrospinal fluid proteomics in meningitis patients with reactivated varicella zoster virus
de réir: Huili Liu, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Comparative Analysis of the Simian Varicella Virus and Varicella Zoster Virus Genomes
de réir: Wayne L. Gray
Foilsithe / Cruthaithe: (2022-04-01)

Varicella zoster virus vaccines: an update
de réir: Gabutti G, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Varicella Zoster Virus Vasculopathies
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2008-03-01)

Varicella Zoster Virus Encephalitis
de réir: Jared Lizzi, et al.
Foilsithe / Cruthaithe: (2019-11-01)